165 related articles for article (PubMed ID: 25276255)
1. Serum anti-glycan antibodies in paediatric-onset Crohn's disease: association with disease phenotype and diagnostic accuracy.
Sładek M; Wasilewska A; Swiat A; Cmiel A
Prz Gastroenterol; 2014; 9(4):232-41. PubMed ID: 25276255
[TBL] [Abstract][Full Text] [Related]
2. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
[TBL] [Abstract][Full Text] [Related]
3. The Correlation between New Serological Markers and Disease Phenotype and Activation in Inflammatory Bowel Disease.
Yorulmaz E; Adalı G; Yorulmaz H; Taşan G; Gürses S; Ayaş MR; Tuncer İ
Middle East J Dig Dis; 2022 Jul; 14(3):294-303. PubMed ID: 36619271
[No Abstract] [Full Text] [Related]
4. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of serological biomarkers in patients with Crohn's disease: A case-control study.
Yao F; Fan Y; Lv B; Ji C; Xu L
Medicine (Baltimore); 2018 Aug; 97(32):e11772. PubMed ID: 30095633
[TBL] [Abstract][Full Text] [Related]
6. Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior.
Rieder F; Schleder S; Wolf A; Dirmeier A; Strauch U; Obermeier F; Lopez R; Spector L; Fire E; Yarden J; Rogler G; Dotan N; Klebl F
Inflamm Bowel Dis; 2010 Feb; 16(2):263-74. PubMed ID: 19653286
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of anti-glycan antibodies in pediatric Crohn's disease in comparison with an adult cohort.
Rieder F; Hahn P; Finsterhoelzl L; Schleder S; Wolf A; Dirmeier A; Lopez R; Shen B; Rogler G; Klebl F; Lang T
Inflamm Bowel Dis; 2012 Jul; 18(7):1221-31. PubMed ID: 22147427
[TBL] [Abstract][Full Text] [Related]
8. Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease.
Goren I; Yahav L; Tulchinsky H; Dotan I
Inflamm Bowel Dis; 2015 Oct; 21(10):2289-95. PubMed ID: 26197448
[TBL] [Abstract][Full Text] [Related]
9. New serologic markers for inflammatory bowel disease diagnosis.
Dotan I
Dig Dis; 2010; 28(3):418-23. PubMed ID: 20926866
[TBL] [Abstract][Full Text] [Related]
10. Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis.
Rieder F; Lopez R; Franke A; Wolf A; Schleder S; Dirmeier A; Schirbel A; Rosenstiel P; Dotan N; Schreiber S; Rogler G; Klebl F
PLoS One; 2011 May; 6(5):e18172. PubMed ID: 21573154
[TBL] [Abstract][Full Text] [Related]
11. Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort.
Malickova K; Lakatos PL; Bortlik M; Komarek V; Janatkova I; Lukas M
Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):144-50. PubMed ID: 19927001
[TBL] [Abstract][Full Text] [Related]
12. Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch.
Werner L; Sturm A; Roggenbuck D; Yahav L; Zion T; Meirowithz E; Ofer A; Guzner-Gur H; Tulchinsky H; Dotan I
J Crohns Colitis; 2013 Dec; 7(11):e522-32. PubMed ID: 23639628
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory bowel disease serology in Asia and the West.
Prideaux L; Kamm MA; De Cruz P; van Langenberg DR; Ng SC; Dotan I
World J Gastroenterol; 2013 Oct; 19(37):6207-13. PubMed ID: 24115818
[TBL] [Abstract][Full Text] [Related]
14. Serological markers of inflammatory bowel disease.
Kuna AT
Biochem Med (Zagreb); 2013; 23(1):28-42. PubMed ID: 23457764
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of anti-glycan antibodies in patients with cystic fibrosis.
Hirche TO; Stein J; Hirche H; Hausmann J; Wagner TO; Behrens F; Schröder O
Eur J Med Res; 2011 Sep; 16(9):385-90. PubMed ID: 22024437
[TBL] [Abstract][Full Text] [Related]
16. The value of serum antibodies in differentiating inflammatory bowel disease, predicting disease activity and disease course in the newly diagnosed patient.
Smids C; Horjus Talabur Horje CS; Groenen MJM; van Koolwijk EHM; Wahab PJ; van Lochem EG
Scand J Gastroenterol; 2017 Oct; 52(10):1104-1112. PubMed ID: 28661185
[TBL] [Abstract][Full Text] [Related]
17. Novel anti-carbohydrate autoantibodies in patients with inflammatory bowel disease: are they useful for clinical practice?
Malickova K; Lukas M; Donoval R; Sandova P; Janatkova I
Clin Lab; 2006; 52(11-12):631-8. PubMed ID: 17175895
[TBL] [Abstract][Full Text] [Related]
18. Antiglycan antibodies in Greek patients with inflammatory bowel disease.
Koutroubakis IE; Drygiannakis D; Tsirogianni A; Oustamanolakis P; Karmiris K; Papamichael K; Mantzaris GJ; Kouroumalis EA
Dig Dis Sci; 2011 Mar; 56(3):845-52. PubMed ID: 20632100
[TBL] [Abstract][Full Text] [Related]
19. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour.
Ferrante M; Henckaerts L; Joossens M; Pierik M; Joossens S; Dotan N; Norman GL; Altstock RT; Van Steen K; Rutgeerts P; Van Assche G; Vermeire S
Gut; 2007 Oct; 56(10):1394-403. PubMed ID: 17456509
[TBL] [Abstract][Full Text] [Related]
20. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]